Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients with undetectable PSA levels.

RANCHO CUCAMONGA, CA / ACCESS Newswire/ December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...

AbbVie announced that a new 6-month 45mg Lupron Depot (leuprolide acetate for extended-release injectable suspension) strength has received Health Canada approval for the treatment of advanced ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: ...

Zydus Lifesciences has strengthened its US oncology portfolio with a fresh approval from the United States Food and Drug Administration for Leuprolide Acetate Injection, 14 mg/2.8 mL, supplied as a ...

Zydus Lifesciences receives USFDA approval for generic Leuprolide Acetate injection, used in advanced prostatic cancer treatment. New Delhi, Nov 14 (PTI) Zydus Lifesciences Ltd on Friday said it has ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose ...

“The escalating public health issue of antimicrobial resistance and emergence of highly resistant organisms demands immediate attention and innovative therapeutic solutions. The approval of CONTEPO is ...

Fosfomycin has a novel mechanism of action and is the only IV-administered epoxide antibacterial antibiotic approved in the US Approval marks the second branded product in Meitheal’s portfolio and ...

A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...

An Immigration and Customs Enforcement memo said that National Guard troops would assist in the deportation process for migrants in their custody. By Chris Cameron Hamed Aleaziz and Eric Schmitt ...

HHS Secretary Robert F. Kennedy Jr. has vowed to find the cause of autism by September 2025. To lead this ambitious endeavor, Kennedy hired David Geier, who has no medical license or scientific ...